Erratum: Impact of S-Adenosylmethionine Decarboxylase 1 on Pulmonary Vascular Remodeling (Circulation (2014) 129 (1510-1523) DOI: 10.1161/CIRCULATIONAHA.113.006402);Impact of S-adenosylmethionine decarboxylase 1 on pulmonary vascular remodeling

Circulation

Volumn 129, Issue 14, 2014, Pages 1510-1523

  Weisel, Friederike Christine ^a   Kloepping, Christina ^a   Pichl, Alexandra ^a   Sydykov, Akylbek ^a   Kojonazarov, Baktybek ^a   Wilhelm, Jochen ^a   Roth, Markus ^a   Ridge, Karen Marie ^b   Igarashi, Kazuei ^c   Nishimura, Kazuhiro ^c   Maison, Wolfgang ^d   Wackendorff, Claudia ^d   Klepetko, Walter ^e   Jaksch, Peter ^e   Ghofrani, Hossein Ardeschir ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a,f   Schermuly, Ralph Theo ^a   Weissmann, Norbert ^a   Kwapiszewska, Grazyna ^g  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHIBA UNIVERSITY   (Japan)

^d UNIVERSITY OF HAMBURG   (Germany)

^e UNIVERSITY OF VIENNA   (Austria)

^f MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^g LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

cell hypoxia; hypertension; muscle; pulmonary; smooth

Indexed keywords

ADENOSYLMETHIONINE DECARBOXYLASE; ADENOSYLMETHIONINE DECARBOXYLASE 1; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C GAMMA1; PLACEBO; SARDOMOZIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; GENE INACTIVATION; GENE SILENCING; GENETIC SCREENING; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN SITU HYBRIDIZATION; IN VIVO STUDY; LONG TERM EXPOSURE; LUNG BLOOD VESSEL; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PULMONARY ARTERY; PULMONARY HYPERTENSION; REOXYGENATION; SMOOTH MUSCLE FIBER; TREATMENT DURATION;

CELL HYPOXIA; HYPERTENSION, PULMONARY; MUSCLE, SMOOTH;

ADENOSYLMETHIONINE DECARBOXYLASE; ADULT; AGED; ANIMALS; ANOXIA; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 1; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; SIGNAL TRANSDUCTION;

EID: 84898028240     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000001068     Document Type: Erratum

References (46)

1. Boutet K, Montani D, Jaïs X, Yaïci A, Sitbon O, Simonneau G, Humbert M. Therapeutic advances in pulmonary arterial hypertension. Ther Adv Respir Dis. 2008;2:249-265.
2. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99:675-691. (Pubitemid 44498302)
3. Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther. 2001;92:1-20. (Pubitemid 34032020)
4. Mecham RP, Whitehouse LA, Wrenn DS, Parks WC, Griffn GL, Senior RM, Crouch EC, Stenmark KR, Voelkel NF. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science. 1987;237:423-426.
5. Botney MD, Bahadori L, Gold LI. Vascular remodeling in primary pulmonary hypertension: potential role for transforming growth factor-beta. Am J Pathol. 1994;144:286-295. (Pubitemid 24165949)
6. Pak O, Aldashev A, Welsh D, Peacock A. The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J. 2007;30:364-372. (Pubitemid 47201724)
7. Hislop A, Reid L. Changes in the pulmonary arteries of the rat during recovery from hypoxia-induced pulmonary hypertension. Br J Exp Pathol. 1977;58:653-662. (Pubitemid 8375480)
8. Prosser IW, Stenmark KR, Suthar M, Crouch EC, Mecham RP, Parks WC. Regional heterogeneity of elastin and collagen gene expression in intra-lobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am J Pathol. 1989;135:1073-1088. (Pubitemid 20026527)
9. Olson JW, Hacker AD, Atkinson JE, Altiere RJ, Gillespie MN. Polyamine content in rat lung during development of hypoxia-induced pulmonary hypertension. Biochem Pharmacol. 1986;35:714-716. (Pubitemid 16049191)
10. Shiao RT, Kostenbauder HB, Olson JW, Gillespie MN. Mechanisms of lung polyamine accumulation in chronic hypoxic pulmonary hypertension. Am J Physiol. 1990;259(pt 1):L351-L358.
11. Atkinson JE, Olson JW, Altiere RJ, Gillespie MN. Evidence that hypoxic pulmonary vascular remodeling in rats is polyamine dependent. J Appl Physiol (1985). 1987;62:1562-1568. (Pubitemid 17070441)
12. Weissmann N, Nollen M, Gerigk B, Ardeschir Ghofrani H, Schermuly RT, Gunther A, Quanz K, Fink L, Hänze J, Rose F, Seeger W, Grimminger F. Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide. Am J Physiol Heart Circ Physiol. 2003;284:H931-H938. (Pubitemid 36228242)
13. Stanek J, Caravatti G, Frei J, Furet P, Mett H, Schneider P, Regenass U. 4-Amidinoindan-1-one 2'-amidinohydrazone: a new potent and selective inhibitor of S-Adenosylmethionine decarboxylase. J Med Chem. 1993;36:2168-2171. (Pubitemid 23241150)
14. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2007.
15. Smyth GK. Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. 2005:397-420.
16. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
17. Mittal M, Roth M, König P, Hofmann S, Dony E, Goyal P, Selbitz AC, Schermuly RT, Ghofrani HA, Kwapiszewska G, Kummer W, Klepetko W, Hoda MA, Fink L, Hänze J, Seeger W, Grimminger F, Schmidt HH, Weissmann N. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res. 2007;101:258-267. (Pubitemid 47344075)
18. Marshall C, Mamary AJ, Verhoeven AJ, Marshall BE. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am J Respir Cell Mol Biol. 1996;15:633-644. (Pubitemid 126440603)
19. Waypa GB, Chandel NS, Schumacker PT. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res. 2001;88:1259-1266. (Pubitemid 32587842)
20. Izikki M, Guignabert C, Fadel E, Humbert M, Tu L, Zadigue P, Dartevelle P, Simonneau G, Adnot S, Maitre B, Raffestin B, Eddahibi S. Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J Clin Invest. 2009;119:512-523.
21. Hänze J, Weissmann N, Grimminger F, Seeger W, Rose F. Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling. Thromb Haemost. 2007;97:774-787. (Pubitemid 46779962)
22. Kaufmann K, Thiel G. Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc fnger transcription factor, in human malignant glioma cells. J Neurol Sci. 2001;189:83-91. (Pubitemid 32776653)
23. Nishimura K, Liisanantti M, Muta Y, Kashiwagi K, Shirahata A, Jänne M, Kankare K, Jänne OA, Igarashi K. Structure and activity of mouse S-adenosylmethionine decarboxylase gene promoters and properties of the encoded proteins. Biochem J. 1998;332(pt 3):651-659. (Pubitemid 28306689)
24. Abraham AS, Kay JM, Cole RB, Pincock AC. Haemodynamic and pathological study of the effect of chronic hypoxia and subsequent recovery of the heart and pulmonary vasculature of the rat. Cardiovasc Res. 1971;5:95-102.
25. Nishimura K, Nakatsu F, Kashiwagi K, Ohno H, Saito T, Igarashi K. Essential role of S-adenosylmethionine decarboxylase in mouse embryonic development. Genes Cells. 2002;7:41-47. (Pubitemid 34121304)
26. Russell D, Snyder SH. Amine synthesis in rapidly growing tissues: orni-thine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci USA. 1968;60:1420-1427.
27. Takigawa M, Enomoto M, Nishida Y, Pan HO, Kinoshita A, Suzuki F. Tumor angiogenesis and polyamines: alpha-difuoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro. Cancer Res. 1990;50:4131-4138. (Pubitemid 20225641)
28. Takahashi Y, Mai M, Nishioka K. alpha-difuoromethylornithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model. Int J Cancer. 2000;85:243-247. (Pubitemid 30023074)
29. Staub NC. Site of hypoxic pulmonary vasoconstriction. Chest. 1985;88(suppl):240S-245S. (Pubitemid 16255480)
30. Olson JW, Altiere RJ, Gillespie MN. Prolonged activation of rat lung orni-thine decarboxylase in monocrotaline-induced pulmonary hypertension. Biochem Pharmacol. 1984;33:3633-3637. (Pubitemid 15220942)
31. Pendeville H, Carpino N, Marine JC, Takahashi Y, Muller M, Martial JA, Cleveland JL. The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol. 2001;21:6549-6558. (Pubitemid 32927422)
32. Harrod KS, Olson JW, Gillespie MN. Regulation of ornithine decarbox-ylase by hypoxia in pulmonary artery smooth muscle cells. Am J Physiol. 1996;271(pt 1):L31-L37. (Pubitemid 26295102)
33. Stenmark KR, Davie N, Frid M, Gerasimovskaya E, Das M. Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda). 2006;21:134-145. (Pubitemid 43752509)
34. Jiang Y, Dai A, Li Q, Hu R. Hypoxia induces transforming growth factor-beta1 gene expression in the pulmonary artery of rats via hypoxia-inducible factor-1alpha. Acta Biochim Biophys Sin (Shanghai). 2007;39:73-80. (Pubitemid 46115039)
35. Swinson DE, O'Byrne KJ. Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer. Clin Lung Cancer. 2006;7:250-256. (Pubitemid 43280027)
36. Gillespie MN, Olson JW. Polyamine regulatory pathways as pharma-cologic targets in pulmonary arterial hypertension. Adv Exp Med Biol. 2010;661:375-389.
37. Hardin MS, Hurta RA. Growth factor-mediated altered expression and regulation of S-adenosylmethionine decarboxylase in a H-ras transformed cell line capable of malignant progression. J Cell Biochem. 2002;84:349-358. (Pubitemid 34033293)
38. Milovic V, Turhanowa L, Fares FA, Lerner A, Caspary WF, Stein J. S-adenosylmethionine decarboxylase activity and utilization of exogenous putrescine are enhanced in colon cancer cells stimulated to grow by EGF. Z Gastroenterol. 1998;36:947-954. (Pubitemid 28547212)
39. Ghazvini-Boroujerdi M, Clark J, Narula N, Palmatory E, Connolly JM, DeFelice S, Xu J, Jian B, Hazelwood S, Levy RJ. Transcription factor Egr-1 in calcifc aortic valve disease. J Heart Valve Dis. 2004;13:894-903.
40. Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, Noble PW, Yehualaeshet T, Lu B, Flavell RA, Milbrandt J, Homer RJ, Elias JA. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fbrosis. J Exp Med. 2004;200:377-389. (Pubitemid 39031256)
41. Merklinger SL, Jones PL, Martinez EC, Rabinovitch M. Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension. Circulation. 2005;112:423-431. (Pubitemid 41022085)
42. Fukuda N. Cigarette smoking induces vascular proliferative disease through the activation of Egr-1. Cardiovasc Res. 2010;88:207-208.
43. Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 1984;312:315-321. (Pubitemid 15209307)
44. Weir EK, Olschewski A. Role of ion channels in acute and chronic responses of the pulmonary vasculature to hypoxia. Cardiovasc Res. 2006;71:630-641. (Pubitemid 44848001)
45. Manni A, Washington S, Hu X, Griffth JW, Bruggeman R, Demers LM, Mauger D, Verderame MF. Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells. Clin Exp Metastasis. 2005;22:255-263. (Pubitemid 41298007)
46. Gillespie MN, Rippetoe PE, Haven CA, Shiao RT, Orlinska U, Maley BE, Olson JW. Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension. Am Rev Respir Dis. 1989;140:1463-1466. (Pubitemid 19276243)